Doxorubicin Liposomal Injection Clinical Trials

• The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (Study P04445)
  ClinicalTrials.gov Identifier: NCT00266799 - Recruiting
  Breast Cancer
  
• Ph 3 Randomized Study of Telcyta® + Liposomal Doxorubicin Vs Liposomal Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00350948 - Suspended
  Ovarian Neoplasms
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00027989 - Active, not recruiting
  stage IV breast cancer
  
• Maintenance Treatment with Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00128778 - Completed
  Breast Neoplasms
  
• Liposomal Doxorubicin in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004014 - Active, not recruiting
  Quality of Life; recurrent prostate cancer
  
• Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00030784 - Active, not recruiting
  adult soft tissue sarcoma
  
• Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.
  ClinicalTrials.gov Identifier: NCT00002147 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women with Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005980 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00002318 - Active, not recruiting
  Sarcoma, Kaposi; HIV Infections
  
• VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin
  ClinicalTrials.gov Identifier: NCT00004030 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00255801 - Recruiting
  Lymphoma
  
• Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00244985 - Recruiting
  Lymphoma
  
• Vincristine, DOXIL® (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00344422 - Active, not recruiting
  M-Protein; Multiple Myeloma; Myeloma; Myeloma Proteins
  
• Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
  ClinicalTrials.gov Identifier: NCT00093444 - Active, not recruiting
  Liver Cancer; Metastatic Cancer
  
• MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00326456 - Active, not recruiting
  Ovarian Cancer
  
• Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours
  ClinicalTrials.gov Identifier: NCT00189410 - Active, not recruiting
  Cancer of the Ovary Treated as 2nd Line Therapy; Muellerian Mixed Tumours; Tumours of the Uterus; Cervical Cancers; Non-Epithelial Ovarian Tumours
  
• Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00355888 - Recruiting
  Cancer
  
• Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006825 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Comparison of Liposomal Doxorubicin Used Alone or in Combination with Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00001059 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Bortezomib and Liposomal Doxorubicin in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00088855 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer
  ClinicalTrials.gov Identifier: NCT00346229 - Recruiting
  Breast Cancer
  
• A Randomized Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler Imaging
  ClinicalTrials.gov Identifier: NCT00531973 - Recruiting
  Breast Cancer
  
• Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00002105 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00524459 - Recruiting
  Breast Cancer
  
• Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00296010 - Recruiting
  Breast Cancer
  
• A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00516191 - Recruiting
  Multiple Myeloma
  
• Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00426127 - Recruiting
  Pancreatic Cancer
  
• Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer
  ClinicalTrials.gov Identifier: NCT00465673 - Recruiting
  Breast Cancer
  
• Multi-National, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)
  ClinicalTrials.gov Identifier: NCT00538603 - Active, not recruiting
  Epithelial Ovarian Cancer
  
• Liposomal Doxorubicin and Docetaxel in Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00377559 - Recruiting
  Breast Cancer; Neoplasm Metastasis
  
• Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00290732 - Recruiting
  Breast Cancer
  
• Liposomal Doxorubicin, Trastuzumab, and Docetaxel in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00377780 - Recruiting
  Breast Cancer; Neoplasm Metastasis
  
• Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-Line or Later Therapy in Patients With Müllerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Pl
  ClinicalTrials.gov Identifier: NCT00216645 - Completed
  Ovarian Neoplasms
  
• Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00524810 - Active, not recruiting
  Metastatic Breast Cancer
  
• Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
  ClinicalTrials.gov Identifier: NCT00032162 - Active, not recruiting
  Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; uterine sarcoma; ovarian sarcoma; ovarian carcinosarcoma
  
• Pegylated Liposomal Doxorubicin Compared to Capecitabine in Treating Women 60 Years and Older with Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00082095 - Terminated
  Breast Cancer
  
• Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004925 - Active, not recruiting
  stage IIIB breast cancer; inflammatory breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection
  ClinicalTrials.gov Identifier: NCT00003315 - Active, not recruiting
  Infection
  
• Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00043082 - Active, not recruiting
  peritoneal cavity cancer; recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004162 - Active, not recruiting
  AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related diffuse mixed cell lymphoma; ...
  
• Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00258960 - Recruiting
  Breast Cancer
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00004236 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
  
• Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)
  ClinicalTrials.gov Identifier: NCT00183742 - Completed
  Cancer; Carcinoma
  
• Ixabepilone and Liposomal Doxorubicin in Treating Patients With Advanced Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00182767 - Recruiting
  Breast Cancer; Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00148317 - Recruiting
  Multiple Myeloma
  
• Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
  ClinicalTrials.gov Identifier: NCT00179725 - Terminated
  Ovarian Cancer
  
• Thal/Dex (Thalidomide and Dexamethasone) vs. Dd-T (Doxil, Dexamethasone and Thalidomide) in Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00097981 - Active, not recruiting
  Multiple Myeloma
  
• Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer, Metastatic Breast Cancer, or Advanced Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00245050 - Recruiting
  Breast Cancer; Drug Toxicity; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
  ClinicalTrials.gov Identifier: NCT00003296 - Active, not recruiting
  recurrent adult primary liver cancer; localized gallbladder cancer; advanced adult primary liver cancer; cholangiocarcinoma of the gallbladder; ...
  
• Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00020449 - Completed
  Sarcoma
  
• ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
  ClinicalTrials.gov Identifier: NCT00003034 - Active, not recruiting
  localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
  
• END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin
  ClinicalTrials.gov Identifier: NCT00401635 - Completed
  Endometrial Cancer
  
• Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004207 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Pharmacology Study of Aerosolized Liposomal
  ClinicalTrials.gov Identifier: NCT00250120 - Active, not recruiting
  Lung Diseases; Cancer
  
• Osteosarcoma1999-A Study Of Intensive Chemotherapy Utilizing Ifosfamide, Carboplatin, and Doxorubicin for Adjuvant Chemotherapy For Treatment Of Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00145639 - Active, not recruiting
  Osteosarcoma
  
• Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
  ClinicalTrials.gov Identifier: NCT00074087 - Recruiting
  stage II mycosis fungoides/Sezary syndrome; stage IV mycosis fungoides/Sezary syndrome; recurrent mycosis fungoides/Sezary syndrome; ...
  
• Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients with Non-Small-Cell Lung Carcinoma (NSCLC)
  ClinicalTrials.gov Identifier: NCT00082472 - Active, not recruiting
  NSCLC
  
• Phase II Clinical Study of a Liposomal-Cisplatin Analogue (L-NDDP) Administered Intrapleurally in Patients with Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00004033 - Active, not recruiting
  recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma
  
• Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00003938 - Active, not recruiting
  Kidney Disease; Breast Cancer; Endocrine Cancer; Gastrointestinal Cancer; Hematopoietic and Lymphoid Cancer; Central Nervous System Cancer
  
• Preoperative Treatment of Breast Cancer with Two Different Sequential Treatment Regimens
  ClinicalTrials.gov Identifier: NCT00149214 - Active, not recruiting
  Breast Neoplasms
  
• Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00036790 - Active, not recruiting
  Cancer
  
• Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00003350 - Active, not recruiting
  epidemic Kaposi's sarcoma
  
• ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00016172 - Active, not recruiting
  Leukemia; Lymphoma; Eye Cancer
  
• Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00004083 - Active, not recruiting
  stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer
  
• Safety, Efficacy and Pharmacokinetics Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00148148 - Recruiting
  "Hematopoietic Stem Cell Transplantation"
  
• TLK286 (Telcyta) in Combination w/Carboplatin (Paraplatin) vs. Doxil in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00102973 - Completed
  Ovarian Neoplasms
  
• Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00008359 - Active, not recruiting
  Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; Eye Cancer; kidney tumor
  
• 3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00079014 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005991 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002721 - Active, not recruiting
  recurrent prostate cancer
  
• Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00008073 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Phase I/II Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients with Advanced Stages Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00147875 - Active, not recruiting
  Hodgkin''s Disease
  
• Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00061867 - Completed
  adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer
  
• Doxorubicin in Treating Women With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003165 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00003212 - Active, not recruiting
  Soft Tissue Sarcoma; Uterine Cancer
  
• Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00019630 - Completed
  Childhood Soft Tissue Sarcoma; Childhood Liver Cancer; Bone Cancer; Brain Tumor; Kidney Tumor
  
• Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel Or Doxorubicin in Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00123929 - Recruiting
  Breast Cancer
  
• Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone OR Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Rituximab Followed by Vaccine Therapy Plus Sargramostim in Treating Patients With Stage II, Stage III, or Stage IV Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00019981 - Recruiting
  Lymphoma
  
• Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00030472 - Completed
  recurrent cervical cancer; stage IVB cervical cancer; cervical squamous cell carcinoma
  
• Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003682 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003035 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• Doxorubicin With or Without Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00079027 - Active, not recruiting
  advanced adult primary liver cancer; adult primary hepatocellular carcinoma
  
• Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
  ClinicalTrials.gov Identifier: NCT00250068 - Recruiting
  Lung Diseases; Cancer
  
• Liposomal Doxorubicin in Treating Patients with Advanced or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00005861 - Completed
  stage III endometrial cancer; stage IV endometrial cancer; recurrent endometrial cancer
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant
  ClinicalTrials.gov Identifier: NCT00089180 - Recruiting
  recurrent skin cancer; basal cell carcinoma of the skin; squamous cell carcinoma of the skin; actinic keratosis
  
• Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
  ClinicalTrials.gov Identifier: NCT00250016 - Recruiting
  Corpus Uteri; Endometrial Cancer
  
• Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00201695 - Suspended
  Multiple Myeloma
  
• Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
  ClinicalTrials.gov Identifier: NCT00249990 - Recruiting
  Corpus Uteri; Endometrial Cancer
  
• Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005800 - Active, not recruiting
  stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer
  
• Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00080782 - Active, not recruiting
  recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors
  ClinicalTrials.gov Identifier: NCT00305084 - Active, not recruiting
  Cancer
  
• Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
  ClinicalTrials.gov Identifier: NCT00004067 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer
  
• A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00002319 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• TLK286 Compared With Either Liposomal Doxorubicin or Topotecan as Third-Line Therapy in Treating Patients With Platinum-Refractory or Platinum-Resistant Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00078884 - Completed
  Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer